(2002). A direct approach to false discovery rates.
(2006). A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
(2004). Accumulated evidence on fish consumption and coronary heart disease mortality.
(2006). Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance.
(2008). Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults.
(2003). Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study.
(2006). Ceramides in insulin resistance and lipotoxicity.
(2007). Chicco A
(2007). Core Team
(2001). Creactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease.
(2006). Diet and Lifestyle Recommendations Revision
(1997). Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide.
(1999). Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects.
(2008). Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications.
(2007). Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
(2006). Fish intake and serum fatty acid profiles from freshwater fish.
(2007). Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?
(1991). Inverse association between fish intake and risk of glucose intolerance in normoglycemis elderly men and women.
(2007). Lipid mediators of insulin resistance.
(2008). Lipid signalling in disease.
(1999). Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a plateletactivating factor (PAF) receptor-dependent mechanism. Clin Exp immunol 116:
(2007). Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells.
(1994). Molecular species of ethanolamine plasmalogens and transacylase activity in rat tissues are altered by fish oil diets.
(2008). Muscular diacylglycerol metabolism and insulin resistance. Physiology & Behavior,
(2006). N-3 Fatty acids and cardiovascular disease.
(2006). N-3 Fatty acids from fish or fish-oil supplements, but not a-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.
(2005). N-3 Long-Chain Polyunsaturated Fatty Acids in Type 2 Diabetes: A Review.
(2002). N-3 Polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
(2006). Ores ˇic ˇ M
(1999). Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line: insights using ether lipid-deficient variants.
(2004). Plasmalogens: targets for oxidants and major lipophilic antioxidants.
(2007). The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype.
(1993). The relation between insulin sensitivity and the fatty-acid composition of skeletal muscle phospholipids.